{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:21:03Z","timestamp":1783056063438,"version":"3.54.6"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82200605"],"award-info":[{"award-number":["82200605"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04898-z","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:23:31Z","timestamp":1778505811000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Specific alterations in the gut microbiome and metabolome across disease locations of Crohn\u2019s disease: a systematic review"],"prefix":"10.1186","volume":"26","author":[{"given":"Jieqing","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhirong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"4898_CR1","doi-asserted-by":"publisher","first-page":"549","DOI":"10.7861\/clinmed.2023-0493","volume":"23","author":"E Cockburn","year":"2023","unstructured":"Cockburn E, Kamal S, Chan A, Rao V, Liu T, Huang JY, et al. Crohn\u2019s disease: an update. Clin Med (Lond). 2023;23:549\u201357.","journal-title":"Clin Med (Lond)"},{"key":"4898_CR2","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/gut.2005.082909","volume":"55","author":"J Satsangi","year":"2006","unstructured":"Satsangi J, Silverberg MS, Vermeire S, Colombel J. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749\u201353.","journal-title":"Gut"},{"key":"4898_CR3","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1053\/j.gastro.2011.01.055","volume":"140","author":"J Cosnes","year":"2011","unstructured":"Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140:1785\u201394.","journal-title":"Gastroenterology"},{"key":"4898_CR4","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1053\/j.gastro.2013.04.007","volume":"145","author":"SC Ng","year":"2013","unstructured":"Ng SC, Tang W, Ching JY, Wong M, Chow CM, Hui AJ, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-Pacific Crohn\u2019s and colitis epidemiology study. Gastroenterology. 2013;145:158\u2013e1652.","journal-title":"Gastroenterology"},{"key":"4898_CR5","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3390\/cells8080817","volume":"8","author":"G Roda","year":"2019","unstructured":"Roda G, Porru E, Katsanos K, Skamnelos A, Kyriakidi K, Fiorino G, et al. Serum bile acids profiling in inflammatory bowel disease patients treated with anti-TNFs. Cells. 2019;8:817.","journal-title":"Cells"},{"key":"4898_CR6","doi-asserted-by":"publisher","first-page":"11525","DOI":"10.3748\/wjg.v20.i33.11525","volume":"20","author":"SJ Park","year":"2014","unstructured":"Park SJ, Kim WH, Cheon JH. Clinical characteristics and treatment of inflammatory bowel disease: A comparison of Eastern and Western perspectives. World J Gastroenterol. 2014;20:11525\u201337.","journal-title":"World J Gastroenterol"},{"key":"4898_CR7","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(16)31711-1","volume":"389","author":"J Torres","year":"2017","unstructured":"Torres J, Mehandru S, Colombel J-F, Peyrin-Biroulet L. Crohn\u2019s disease. Lancet. 2017;389:1741\u201355.","journal-title":"Lancet"},{"key":"4898_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12328-017-0813-5","volume":"11","author":"A Nishida","year":"2018","unstructured":"Nishida A, Inoue R, Inatomi O, Bamba S, Naito Y, Andoh A. Gut microbiota in the pathogenesis of inflammatory bowel disease. Clin J Gastroenterol. 2018;11:1\u201310.","journal-title":"Clin J Gastroenterol"},{"key":"4898_CR9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev.biochem.72.121801.161712","volume":"72","author":"DW Russell","year":"2003","unstructured":"Russell DW. The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem. 2003;72:137\u201374.","journal-title":"Annu Rev Biochem"},{"key":"4898_CR10","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1111\/apt.13570","volume":"43","author":"N Mottacki","year":"2016","unstructured":"Mottacki N, Simr\u00e9n M, Bajor A. Review article: bile acid diarrhoea-pathogenesis, diagnosis and management. Aliment Pharmacol Ther. 2016;43:884\u201398.","journal-title":"Aliment Pharmacol Ther"},{"key":"4898_CR11","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/ibd.20783","volume":"15","author":"B Willing","year":"2009","unstructured":"Willing B, Halfvarson J, Dicksved J, Rosenquist M, J\u00e4rnerot G, Engstrand L, et al. Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn\u2019s disease. Inflamm Bowel Dis. 2009;15:653\u201360.","journal-title":"Inflamm Bowel Dis"},{"key":"4898_CR12","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1093\/ibd\/izaa103","volume":"26","author":"NM Shahir","year":"2020","unstructured":"Shahir NM, Wang JR, Wolber EA, Schaner MS, Frank DN, Ir D, et al. Crohn\u2019s disease differentially affects region-specific composition and aerotolerance profiles of mucosally adherent bacteria. Inflamm Bowel Dis. 2020;26:1843\u201355.","journal-title":"Inflamm Bowel Dis"},{"key":"4898_CR13","doi-asserted-by":"publisher","first-page":"370","DOI":"10.5217\/ir.2021.00054","volume":"20","author":"S Bamba","year":"2022","unstructured":"Bamba S, Inatomi O, Nishida A, Ohno M, Imai T, Takahashi K, et al. Relationship between the gut microbiota and bile acid composition in the ileal mucosa of Crohn\u2019s disease. Intest Res. 2022;20:370\u201380.","journal-title":"Intest Res"},{"key":"4898_CR14","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/ismej.2008.37","volume":"2","author":"J Dicksved","year":"2008","unstructured":"Dicksved J, Halfvarson J, Rosenquist M, J\u00e4rnerot G, Tysk C, Apajalahti J, et al. Molecular analysis of the gut microbiota of identical twins with Crohn\u2019s disease. ISME J. 2008;2:716\u201327.","journal-title":"ISME J"},{"key":"4898_CR15","doi-asserted-by":"publisher","first-page":"17004","DOI":"10.1038\/nmicrobiol.2017.4","volume":"2","author":"J Halfvarson","year":"2017","unstructured":"Halfvarson J, Brislawn CJ, Lamendella R, V\u00e1zquez-Baeza Y, Walters WA, Bramer LM, et al. Dynamics of the human gut microbiome in inflammatory bowel disease. Nat Microbiol. 2017;2:17004.","journal-title":"Nat Microbiol"},{"key":"4898_CR16","doi-asserted-by":"publisher","first-page":"615064","DOI":"10.3389\/fnut.2021.615064","volume":"8","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, He Y, Liu L, Zhou W, Wang P, Hu H, et al. Alterations in gut microbial communities across anatomical locations in inflammatory bowel diseases. Front Nutr. 2021;8:615064.","journal-title":"Front Nutr"},{"key":"4898_CR17","doi-asserted-by":"publisher","first-page":"1595884","DOI":"10.3389\/fcimb.2025.1595884","volume":"15","author":"M Orejudo","year":"2025","unstructured":"Orejudo M, G\u00f3mez MJ, Riestra S, Rivero M, Guti\u00e9rrez A, Rodr\u00edguez-Lago I, et al. Exploration of fecal microbiota in newly diagnosed patients with inflammatory bowel disease using shotgun metagenomics. Front Cell Infect Microbiol. 2025;15:1595884.","journal-title":"Front Cell Infect Microbiol"},{"key":"4898_CR18","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1053\/j.gastro.2010.08.049","volume":"139","author":"BP Willing","year":"2010","unstructured":"Willing BP, Dicksved J, Halfvarson J, Andersson AF, Lucio M, Zheng Z, et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology. 2010;139:1844\u2013e18541.","journal-title":"Gastroenterology"},{"key":"4898_CR19","doi-asserted-by":"publisher","first-page":"R79","DOI":"10.1186\/gb-2012-13-9-r79","volume":"13","author":"XC Morgan","year":"2012","unstructured":"Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012;13:R79.","journal-title":"Genome Biol"},{"key":"4898_CR20","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/ismej.2007.52","volume":"1","author":"M Baumgart","year":"2007","unstructured":"Baumgart M, Dogan B, Rishniw M, Weitzman G, Bosworth B, Yantiss R, et al. Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn\u2019s disease involving the ileum. ISME J. 2007;1:403\u201318.","journal-title":"ISME J"},{"key":"4898_CR21","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/ibd.20860","volume":"15","author":"M Martinez-Medina","year":"2009","unstructured":"Martinez-Medina M, Aldeguer X, Lopez-Siles M, Gonz\u00e1lez-Huix F, L\u00f3pez-Oliu C, Dahbi G, et al. Molecular diversity of Escherichia coli in the human gut: new ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohn\u2019s disease. Inflamm Bowel Dis. 2009;15:872\u201382.","journal-title":"Inflamm Bowel Dis"},{"key":"4898_CR22","doi-asserted-by":"publisher","first-page":"e0134382","DOI":"10.1371\/journal.pone.0134382","volume":"10","author":"RJ Chiodini","year":"2015","unstructured":"Chiodini RJ, Dowd SE, Chamberlin WM, Galandiuk S, Davis B, Glassing A. Microbial population differentials between mucosal and submucosal intestinal tissues in advanced Crohn\u2019s disease of the ileum. PLoS ONE. 2015;10:e0134382.","journal-title":"PLoS ONE"},{"key":"4898_CR23","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jcmgh.2016.05.011","volume":"2","author":"CS Pedamallu","year":"2016","unstructured":"Pedamallu CS, Bhatt AS, Bullman S, Fowler S, Freeman SS, Durand J, et al. Metagenomic characterization of microbial communities in situ within the deeper layers of the ileum in Crohn\u2019s disease. Cell Mol Gastroenterol Hepatol. 2016;2:563\u2013e5665.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"4898_CR24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s40168-022-01331-x","volume":"10","author":"CG Gonzalez","year":"2022","unstructured":"Gonzalez CG, Mills RH, Zhu Q, Sauceda C, Knight R, Dulai PS, et al. Location-specific signatures of Crohn\u2019s disease at a multi-omics scale. Microbiome. 2022;10:133.","journal-title":"Microbiome"},{"key":"4898_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s40168-024-01927-5","volume":"12","author":"S Levi Mortera","year":"2024","unstructured":"Levi Mortera S, Marzano V, Rapisarda F, Marangelo C, Pirona I, Vernocchi P, et al. Metaproteomics reveals diet-induced changes in gut microbiome function according to Crohn\u2019s disease location. Microbiome. 2024;12:217.","journal-title":"Microbiome"},{"key":"4898_CR26","doi-asserted-by":"publisher","first-page":"8787","DOI":"10.3748\/wjg.v21.i29.8787","volume":"21","author":"SM Jandhyala","year":"2015","unstructured":"Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Reddy DN. Role of the normal gut microbiota. World J Gastroenterol. 2015;21:8787\u2013803.","journal-title":"World J Gastroenterol"},{"key":"4898_CR27","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.3390\/cells10071775","volume":"10","author":"PS Salvi","year":"2021","unstructured":"Salvi PS, Cowles RA. Butyrate and the intestinal epithelium: modulation of proliferation and inflammation in homeostasis and disease. Cells. 2021;10:1775.","journal-title":"Cells"},{"key":"4898_CR28","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.it.2018.02.008","volume":"39","author":"TP Wypych","year":"2018","unstructured":"Wypych TP, Marsland BJ. Antibiotics as instigators of microbial dysbiosis: implications for asthma and allergy. Trends Immunol. 2018;39:697\u2013711.","journal-title":"Trends Immunol"},{"key":"4898_CR29","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.ijmm.2014.02.009","volume":"304","author":"M Lopez-Siles","year":"2014","unstructured":"Lopez-Siles M, Martinez-Medina M, Busquets D, Sabat-Mir M, Duncan SH, Flint HJ, et al. Mucosa-associated Faecalibacterium prausnitzii and Escherichia coli co-abundance can distinguish irritable bowel syndrome and inflammatory bowel disease phenotypes. Int J Med Microbiol. 2014;304:464\u201375.","journal-title":"Int J Med Microbiol"},{"key":"4898_CR30","doi-asserted-by":"publisher","first-page":"e6386","DOI":"10.1371\/journal.pone.0006386","volume":"4","author":"J Jansson","year":"2009","unstructured":"Jansson J, Willing B, Lucio M, Fekete A, Dicksved J, Halfvarson J, et al. Metabolomics reveals metabolic biomarkers of Crohn\u2019s disease. PLoS ONE. 2009;4:e6386.","journal-title":"PLoS ONE"},{"key":"4898_CR31","doi-asserted-by":"publisher","first-page":"e26284","DOI":"10.1371\/journal.pone.0026284","volume":"7","author":"E Li","year":"2012","unstructured":"Li E, Hamm CM, Gulati AS, Sartor RB, Chen H, Wu X, et al. Inflammatory bowel diseases phenotype, C. difficile and NOD2 genotype are associated with shifts in human ileum associated microbial composition. PLoS ONE. 2012;7:e26284.","journal-title":"PLoS ONE"},{"key":"4898_CR32","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3389\/fcimb.2018.00281","volume":"8","author":"M Lopez-Siles","year":"2018","unstructured":"Lopez-Siles M, Enrich-Cap\u00f3 N, Aldeguer X, Sabat-Mir M, Duncan SH, Garcia-Gil LJ, et al. Alterations in the abundance and co-occurrence of Akkermansia muciniphila and Faecalibacterium prausnitzii in the colonic mucosa of inflammatory bowel disease subjects. Front Cell Infect Microbiol. 2018;8:281.","journal-title":"Front Cell Infect Microbiol"},{"key":"4898_CR33","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/MIB.0000000000000662","volume":"22","author":"T Naftali","year":"2016","unstructured":"Naftali T, Reshef L, Kovacs A, Porat R, Amir I, Konikoff FM, et al. Distinct microbiotas are associated with ileum-restricted and colon-involving Crohn\u2019s disease. Inflamm Bowel Dis. 2016;22:293\u2013302.","journal-title":"Inflamm Bowel Dis"},{"key":"4898_CR34","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1136\/gutjnl-2016-313235","volume":"66","author":"V Pascal","year":"2017","unstructured":"Pascal V, Pozuelo M, Borruel N, Casellas F, Campos D, Santiago A, et al. A microbial signature for Crohn\u2019s disease. Gut. 2017;66:813\u201322.","journal-title":"Gut"},{"key":"4898_CR35","doi-asserted-by":"publisher","first-page":"148","DOI":"10.5217\/ir.2021.00168","volume":"21","author":"SY Shin","year":"2023","unstructured":"Shin SY, Kim Y, Kim W-S, Moon JM, Lee K-M, Jung S-A, et al. Compositional changes in fecal microbiota associated with clinical phenotypes and prognosis in Korean patients with inflammatory bowel disease. Intest Res. 2023;21:148\u201360.","journal-title":"Intest Res"},{"key":"4898_CR36","doi-asserted-by":"publisher","first-page":"2241615","DOI":"10.1080\/13510002.2023.2241615","volume":"28","author":"O Handa","year":"2023","unstructured":"Handa O, Miura H, Gu T, Osawa M, Matsumoto H, Umegaki E, et al. Reduction of butyric acid-producing bacteria in the ileal mucosa-associated microbiota is associated with the history of abdominal surgery in patients with Crohn\u2019s disease. Redox Rep. 2023;28:2241615.","journal-title":"Redox Rep"},{"key":"4898_CR37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2147\/CEG.S186235","volume":"12","author":"C Olbj\u00f8rn","year":"2019","unstructured":"Olbj\u00f8rn C, Cvancarova Sm\u00e5stuen M, Thiis-Evensen E, Nakstad B, Vatn MH, Jahnsen J, et al. Fecal microbiota profiles in treatment-na\u00efve pediatric inflammatory bowel disease-associations with disease phenotype, treatment, and outcome. Clin Exp Gastroenterol. 2019;12:37\u201349.","journal-title":"Clin Exp Gastroenterol"},{"key":"4898_CR38","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1172\/JCI75436","volume":"124","author":"Y Haberman","year":"2014","unstructured":"Haberman Y, Tickle TL, Dexheimer PJ, Kim M-O, Tang D, Karns R, et al. Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature. J Clin Invest. 2014;124:3617\u201333.","journal-title":"J Clin Invest"},{"key":"4898_CR39","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1097\/MIB.0000000000000776","volume":"22","author":"A Assa","year":"2016","unstructured":"Assa A, Butcher J, Li J, Elkadri A, Sherman PM, Muise AM, et al. Mucosa-associated ileal microbiota in new-onset pediatric Crohn\u2019s disease. Inflamm Bowel Dis. 2016;22:1533\u20139.","journal-title":"Inflamm Bowel Dis"},{"key":"4898_CR40","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.4067\/s0034-98872017000901129","volume":"145","author":"M De La Fuente","year":"2017","unstructured":"De La Fuente M, Chahu\u00e1n I, Guti\u00e9rrez R, D\u00edaz-Jim\u00e9nez D, Olivares M, Vidal R, et al. Presence of intracellular Escherichia coli in patients with inflammatory bowel disease. Rev Med Chil. 2017;145:1129\u201336.","journal-title":"Rev Med Chil"},{"key":"4898_CR41","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/gut.2010.223263","volume":"60","author":"M Joossens","year":"2011","unstructured":"Joossens M, Huys G, Cnockaert M, Preter VD, Verbeke K, Rutgeerts P, et al. Dysbiosis of the faecal microbiota in patients with Crohn\u2019s disease and their unaffected relatives. Gut. 2011;60:631\u20137.","journal-title":"Gut"},{"key":"4898_CR42","doi-asserted-by":"publisher","first-page":"13473","DOI":"10.1038\/s41598-019-49833-3","volume":"9","author":"MK Vester-Andersen","year":"2019","unstructured":"Vester-Andersen MK, Mirsepasi-Lauridsen HC, Prosberg MV, Mortensen CO, Tr\u00e4ger C, Skovsen K, et al. Increased abundance of proteobacteria in aggressive Crohn\u2019s disease seven years after diagnosis. Sci Rep. 2019;9:13473.","journal-title":"Sci Rep"},{"key":"4898_CR43","doi-asserted-by":"publisher","first-page":"18880","DOI":"10.1038\/s41598-019-55290-9","volume":"9","author":"K Kowalska-Duplaga","year":"2019","unstructured":"Kowalska-Duplaga K, Gosiewski T, Kapusta P, Sroka-Oleksiak A, W\u0119drychowicz A, Pieczarkowski S, et al. Differences in the intestinal microbiome of healthy children and patients with newly diagnosed Crohn\u2019s disease. Sci Rep. 2019;9:18880.","journal-title":"Sci Rep"},{"key":"4898_CR44","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1080\/00365521.2020.1803396","volume":"55","author":"S Vatn","year":"2020","unstructured":"Vatn S, Carstens A, Kristoffersen AB, Bergemalm D, Cas\u00e9n C, Moen AEF, et al. Faecal microbiota signatures of IBD and their relation to diagnosis, disease phenotype, inflammation, treatment escalation and anti-TNF response in a European Multicentre Study (IBD-Character). Scand J Gastroenterol. 2020;55:1146\u201356.","journal-title":"Scand J Gastroenterol"},{"key":"4898_CR45","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1194\/jlr.R900010-JLR200","volume":"50","author":"JYL Chiang","year":"2009","unstructured":"Chiang JYL. Bile acids: regulation of synthesis. J Lipid Res. 2009;50:1955\u201366.","journal-title":"J Lipid Res"},{"key":"4898_CR46","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1080\/00365521.2024.2328592","volume":"59","author":"A Kiasat","year":"2024","unstructured":"Kiasat A, Prast-Nielsen S, Rautiainen S, Engstrand L, Andersson F, Lindberg J, et al. Plasma bile acids in association with Crohn\u2019s disease. Scand J Gastroenterol. 2024;59:674\u201382.","journal-title":"Scand J Gastroenterol"},{"key":"4898_CR47","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1136\/gutjnl-2012-302578","volume":"62","author":"H Duboc","year":"2013","unstructured":"Duboc H, Rajca S, Rainteau D, Benarous D, Maubert M-A, Quervain E, et al. Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases. Gut. 2013;62:531\u20139.","journal-title":"Gut"},{"key":"4898_CR48","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1365-2362.1982.tb00950.x","volume":"12","author":"P Rutgeerts","year":"1982","unstructured":"Rutgeerts P, Ghoos Y, Vantrappen G. Kinetics of primary bile acids in patients with non-operated Crohn\u2019s disease. Eur J Clin Invest. 1982;12:135\u201343.","journal-title":"Eur J Clin Invest"},{"key":"4898_CR49","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/BF01347906","volume":"31","author":"P Rutgeerts","year":"1986","unstructured":"Rutgeerts P, Ghoos Y, Vantrappen G, Fevery J. Biliary lipid composition in patients with nonoperated Crohn\u2019s disease. Dig Dis Sci. 1986;31:27\u201332.","journal-title":"Dig Dis Sci"},{"key":"4898_CR50","doi-asserted-by":"publisher","first-page":"8416578","DOI":"10.1155\/2022\/8416578","volume":"2022","author":"A Kumar","year":"2022","unstructured":"Kumar A, Al-Hassi HO, Steed H, Phipps O, Brookes MJ. Bile acids and the microbiome: making sense of this dynamic relationship in their role and management in Crohn\u2019s disease. Can J Gastroenterol Hepatol. 2022;2022:8416578.","journal-title":"Can J Gastroenterol Hepatol"},{"key":"4898_CR51","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1007\/s10620-021-06993-5","volume":"67","author":"P Vijayvargiya","year":"2022","unstructured":"Vijayvargiya P, Gonzalez Izundegui D, Calderon G, Tawfic S, Batbold S, Saifuddin H, et al. Increased fecal bile acid excretion in a significant subset of patients with other inflammatory diarrheal diseases. Dig Dis Sci. 2022;67:2413\u20139.","journal-title":"Dig Dis Sci"},{"key":"4898_CR52","doi-asserted-by":"publisher","first-page":"jjaf053","DOI":"10.1093\/ecco-jcc\/jjaf053","volume":"19","author":"R Battat","year":"2025","unstructured":"Battat R, Kandi S, Lacerda AP, Levine P, Neimark E, Feagan BG, et al. Association of bile acid diarrhea with symptoms and disease activity in Crohn\u2019s disease: post-hoc clinical trial analysis of serum 7\u03b1-hydroxy-4-cholesten-3-one, C4, in patients with active Crohn\u2019s disease. J Crohns Colitis. 2025;19:jjaf053.","journal-title":"J Crohns Colitis"},{"key":"4898_CR53","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1038\/s41598-020-58644-w","volume":"10","author":"A Wilson","year":"2020","unstructured":"Wilson A, Almousa A, Teft WA, Kim RB. Attenuation of bile acid-mediated FXR and PXR activation in patients with Crohn\u2019s disease. Sci Rep. 2020;10:1866.","journal-title":"Sci Rep"},{"key":"4898_CR54","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.steroids.2013.05.011","volume":"78","author":"S Ogawa","year":"2013","unstructured":"Ogawa S, Zhou B, Kimoto Y, Omura K, Kobayashi A, Higashi T, et al. An efficient synthesis of 7\u03b1,12\u03b1-dihydroxy-4-cholesten-3-one and its biological precursor 7\u03b1-hydroxy-4-cholesten-3-one: key intermediates in bile acid biosynthesis. Steroids. 2013;78:927\u201337.","journal-title":"Steroids"},{"key":"4898_CR55","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1093\/ibd\/izy022","volume":"24","author":"M Murakami","year":"2018","unstructured":"Murakami M, Iwamoto J, Honda A, Tsuji T, Tamamushi M, Ueda H, et al. Detection of gut dysbiosis due to reduced Clostridium subcluster XIVa using the fecal or serum bile acid profile. Inflamm Bowel Dis. 2018;24:1035\u201344.","journal-title":"Inflamm Bowel Dis"},{"key":"4898_CR56","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.3390\/jcm9051360","volume":"9","author":"M Huhn","year":"2020","unstructured":"Huhn M, Herrero San Juan M, Melcher B, Dreis C, Schmidt KG, Schwiebs A, et al. Inflammation-induced mucosal KYNU expression identifies human ileal Crohn\u2019s disease. J Clin Med. 2020;9:1360.","journal-title":"J Clin Med"},{"key":"4898_CR57","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1053\/j.gastro.2017.08.028","volume":"153","author":"S Nikolaus","year":"2017","unstructured":"Nikolaus S, Schulte B, Al-Massad N, Thieme F, Schulte DM, Bethge J, et al. Increased tryptophan metabolism is associated with activity of inflammatory bowel diseases. Gastroenterology. 2017;153:1504\u2013e15162.","journal-title":"Gastroenterology"},{"key":"4898_CR58","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s00109-021-02094-y","volume":"99","author":"S Notararigo","year":"2021","unstructured":"Notararigo S, Mart\u00edn-Pastor M, Vi\u00f1uela-Rold\u00e1n JE, Quiroga A, Dominguez-Munoz JE, Barreiro-de Acosta M. Targeted \u00b9H-NMR metabolomics and immunological phenotyping of human fresh blood and serum samples discriminate between healthy individuals and inflammatory bowel disease patients treated with anti-TNF. J Mol Med (Berl). 2021;99:1251\u201364.","journal-title":"J Mol Med (Berl)"},{"key":"4898_CR59","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/ibd\/izad154","volume":"30","author":"L Aldars-Garc\u00eda","year":"2024","unstructured":"Aldars-Garc\u00eda L, Gil-Redondo R, Embade N, Riestra S, Rivero M, Guti\u00e9rrez A, et al. Serum and urine metabolomic profiling of newly diagnosed treatment-na\u00efve inflammatory bowel disease patients. Inflamm Bowel Dis. 2024;30:167\u201382.","journal-title":"Inflamm Bowel Dis"},{"key":"4898_CR60","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1093\/ecco-jcc\/jjac079","volume":"16","author":"JZ Jagt","year":"2022","unstructured":"Jagt JZ, Verburgt CM, de Vries R, de Boer NKH, Benninga MA, de Jonge WJ, et al. Faecal metabolomics in paediatric inflammatory bowel disease: a systematic review. J Crohns Colitis. 2022;16:1777\u201390.","journal-title":"J Crohns Colitis"},{"key":"4898_CR61","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/jgh.14356","volume":"34","author":"F Zhu","year":"2019","unstructured":"Zhu F, Feng D, Zhang T, Gu L, Zhu W, Guo Z, et al. Altered uric acid metabolism in isolated colonic Crohn\u2019s disease but not ulcerative colitis. J Gastroenterol Hepatol. 2019;34:154\u201361.","journal-title":"J Gastroenterol Hepatol"},{"key":"4898_CR62","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1093\/ibd\/izac281","volume":"29","author":"R Ferru-Cl\u00e9ment","year":"2023","unstructured":"Ferru-Cl\u00e9ment R, Boucher G, Forest A, Bouchard B, Bitton A, Lesage S, et al. Serum lipidomic screen identifies key metabolites, pathways, and disease classifiers in Crohn\u2019s disease. Inflamm Bowel Dis. 2023;29:1024\u201337.","journal-title":"Inflamm Bowel Dis"},{"key":"4898_CR63","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1097\/MIB.0b013e318281f423","volume":"19","author":"J Iwamoto","year":"2013","unstructured":"Iwamoto J, Saito Y, Honda A, Miyazaki T, Ikegami T, Matsuzaki Y. Bile acid malabsorption deactivates pregnane X receptor in patients with Crohn\u2019s disease. Inflamm Bowel Dis. 2013;19:1278\u201384.","journal-title":"Inflamm Bowel Dis"},{"key":"4898_CR64","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.1007\/s10620-015-3797-3","volume":"60","author":"A Wilson","year":"2015","unstructured":"Wilson A, Teft WA, Morse BL, Choi Y-H, Woolsey S, DeGorter MK, et al. Trimethylamine N-oxide: a novel biomarker for the identification of inflammatory bowel disease. Dig Dis Sci. 2015;60:3620\u201330.","journal-title":"Dig Dis Sci"},{"key":"4898_CR65","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1038\/ajg.2009.175","volume":"104","author":"HRT Williams","year":"2009","unstructured":"Williams HRT, Cox JI, Walker DG, North BV, Patel VM, Marshall SE, et al. Characterization of inflammatory bowel disease with urinary metabolic profiling. Am J Gastroenterol. 2009;104:1435\u201344.","journal-title":"Am J Gastroenterol"},{"key":"4898_CR66","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1136\/gutjnl-2013-306423","volume":"64","author":"VD Preter","year":"2015","unstructured":"Preter VD, Machiels K, Joossens M, Arijs I, Matthys C, Vermeire S, et al. Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD. Gut. 2015;64:447\u201358.","journal-title":"Gut"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04898-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04898-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04898-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:02:12Z","timestamp":1783054932000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04898-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4898"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04898-z","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"13 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. The study was exempt from institutional review board (IRB) review as this is a systematic review of published papers. No patients or human participants were directly involved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"406"}}